DAVID SEITER: Open Payments
NPI 1891190567 · FARMINGTON, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$144,299 in 483 payments from 24 companies in 2025. Trend: 2023 $17,434 · 2024 $26,396 · 2025 $144,299
Speaker / faculty: $106,784Consulting: $14,568Food & beverage: $12,157Travel & lodging: $10,791
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 84 | $38,320 |
| Regeneron Healthcare Solutions, Inc. | 72 | $33,411 |
| Galderma Laboratories, L.P. | 90 | $33,098 |
| GENZYME CORPORATION | 45 | $27,026 |
| Incyte Corporation | 29 | $6,203 |
| Arcutis Biotherapeutics, Inc. | 7 | $1,575 |
| Novartis Pharmaceuticals Corporation | 24 | $1,117 |
| ABBVIE INC. | 25 | $735 |
| Janssen Biotech, Inc. | 15 | $545 |
| LEO Pharma Inc. | 10 | $493 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, COSENTYX, TREMFYA, Opzelura, RINVOQ, Rhapsido.
Industry payments across NM — which companies pay providers there.
